Previous 10 | Next 10 |
Another $1.9T is set to hit the U.S. economy, including direct stimulus checks, after the Senate passed the COVID relief bill on party lines over the weekend.Goldman Sachs' Abby Joseph Cohen tells Bloomberg it's not just a stimulus package, but a "relief package that's getting us out of a hol...
PerkinElmer (PKI) has priced $400M of 2.550% senior notes due 2031 at 99.965% of the principal amount and $400M of 3.625% senior notes due 2051 at 99.999% of the principal amount. Offering is expected to close on March 8.Interest on notes will be payable on a semi-annual basis. The company pl...
The demand for medical devices is growing with increasing numbers of people being vaccinated for COVID-19 and resuming hospital visits for regular or elective surgeries. In addition to increasing hospital admittances for non-COVID-19 treatment, we believe the growing importance of healthcare ...
Precipio ([[PRPO]] +1.6%) appoints Richard Sandberg as its board chairman, succeeding Douglas Fisher who will continue in the role of director.Sandberg has been involved with Precipio since its inception and joined its board in 2019, contributing through strategy form...
Our job as investors is to pay attention to the stocks we own. Part of that involves looking at the fundamentals, but half of the disclosure comes from looking at price action. The Perkinelmer (NYSE: PKI) data table below can help you with price action, and we have more details to...
PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the Barclays Global Healthcare Conference on Wednesday, March 10, 2021 from 9:45 a.m. to 10:10 a.m. ET. Prahlad Singh, president and chi...
Like other life-sciences companies, PerkinElmer (PKI) shifted its business in 2020 to help address the coronavirus pandemic, explains Richard Moroney, editor of Dow Theory Forecasts. For further details see: PerkinElmer- A Good Diagnosis in Life Sciences
Company expands portfolio of SARS-CoV-2 testing solutions with rapid antigen test benchmarked against gold standard RT-PCR PerkinElmer, Inc. (NYSE: PKI) today announced the launch of the PerkinElmer ® COVID-19 Antigen Test for the qualitative detection of SA...
PerkinElmer, Inc. , (NYSE: PKI) a global leader committed to innovating for a healthier world, today provided an update on the COVID-19 Valencia Branch Laboratory’s (VBL) accreditation process. The VBL is operated by PerkinElmer in partnership with the California Department o...
Both opportunity and risk assessments can be drawn from looking at the price action in Perkinelmer (NYSE: PKI). This is a practice commonly referred to as reading the charts. The summary data for PKI below demonstrates this, and there are trading plans that help invest...
News, Short Squeeze, Breakout and More Instantly...
Revenue of $675 million; (30)% reported growth; (27)% organic growth; 6% non-COVID organic growth GAAP EPS of $4.50; Adjusted EPS from continuing operations of $1.01 Updates full year 2023 guidance Authorizes new $600 million share repurchase program To begin tradi...
Transformation aimed at revolutionizing next generation scientific breakthroughs that solve the world’s greatest health challenges Trusted partner to pharma, government and diagnostics customers with complete, end-to-end solutions To begin trading as RVTY under new name on ...
2023-05-07 19:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...